Juan Ramón Alaix is a Spanish business executive and former Chief Executive Officer of Zoetis Inc., the global leader in animal health, where he served as CEO from the company’s formation in 2012 until his retirement from the role at the end of 2019.( During his tenure, Zoetis grew to approximately $5.8 billion in annual revenue in 2018 and achieved a market capitalization of nearly $60 billion, with cumulative total shareholder return of 322% from its 2013 IPO through September 2019.( He continues to serve on the Zoetis Board of Directors and acts as an advisor to the company.(

Alaix brings more than 35 years of experience in finance, sales and management, including two decades in the pharmaceutical industry.( Before leading Zoetis, he was President of Pfizer Animal Health from 2006, having joined Pfizer as a regional president in 2003 following its acquisition of Pharmacia, where he served as country president for Spain.( Earlier in his career, he held general management roles with Rhône-Poulenc Rorer in Spain and Belgium.( He has also served as President of the International Federation for Animal Health (now HealthforAnimals) and was honored with the Deming Cup for Operational Excellence by Columbia Business School in 2018.( A native of Spain, Alaix holds a graduate degree in economics from the Universidad de Madrid.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.